R. Morphy and Z. Rankovic, Designed multiple ligands. An emerging drug discovery paradigm, J. Med. Chem, vol.48, pp.6523-6543, 2005.

G. R. Zimmermann, J. Lehár, and C. T. Keith, Multi-target therapeutics: when the whole is greater than the sum of the parts, Drug Discov. Today, vol.12, pp.34-42, 2007.

R. Morphy and Z. Rankovic, Designing multiple ligands-medicinal chemistry strategies and challenges, Curr. Pharmaceut. Des, vol.15, pp.587-600, 2009.
DOI : 10.2174/138161209787315594

J. L. Medina-franco, M. A. Giulianotti, G. S. Welmaker, and R. A. Houghten, Shifting from the single to the multitarget paradigm in drug discovery, Drug Discov. Today, vol.18, pp.495-501, 2013.

J. Peters, Polypharmacology-foe or friend?, J. Med. Chem, vol.56, pp.8955-8971, 2013.

A. Anighoro, J. Bajorath, and G. Rastelli, Polypharmacology: challenges and opportunities in drug discovery, J. Med. Chem, vol.57, pp.7874-7887, 2014.

K. Nepali, S. Sharma, M. Sharma, P. M. Bedi, and K. L. Dhar, Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids, Eur. J. Med. Chem, vol.77, pp.422-487, 2014.

C. Lecoutey, D. Hedou, T. Freret, P. Giannoni, F. Gaven et al., Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment, Proc. Natl. Acad. Sci. Unit. States Am, vol.111, pp.3825-3830, 2014.

C. Rochais, C. Lecoutey, F. Gaven, P. Giannoni, K. Hamidouche et al., Novel multitarget-directed ligands (MTDLs) with acetylcholinesterase (AChE) inhibitory and serotonergic subtype 4 receptor (5-HT4R) agonist activities as potential agents against Alzheimer's disease: the design of donecopride, J. Med. Chem, vol.58, pp.3172-3187, 2015.

S. Xie, J. Lan, X. Wang, N. Jiang, G. Dong et al., Multifunctional tacrine-trolox hybrids for the treatment of Alzheimer's disease with cholinergic, antioxidant, neuroprotective and hepatoprotective properties, Eur. J. Med. Chem, vol.93, pp.42-50, 2015.

W. J. Geldenhuys, M. B. Youdim, R. T. Carroll, C. J. Van, and . Schyf, The emergence of designed multiple ligands for neurodegenerative disorders, Prog. Neurobiol, vol.94, pp.347-359, 2011.

P. J. Miranda, R. A. Defronzo, R. M. Califf, and J. R. Guyton, Metabolic syndrome: definition, pathophysiology, and mechanisms, Am. Heart J, vol.149, pp.33-45, 2005.

S. M. Grundy, Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy, Nat. Rev. Drug Discov, vol.5, pp.295-309, 2006.

T. W. Kurtz and M. Pravenec, Antidiabetic mechanisms of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists: beyond the renin-angiotensin system, J. Hypertens, vol.22, pp.2253-2261, 2004.

M. Schupp, Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-activity, Circulation, vol.109, pp.2054-2057, 2004.

S. C. Benson, H. A. Pershadsingh, C. I. Ho, A. Chittiboyina, P. Desai et al., Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPAR-modulating activity, Hypertension, vol.43, pp.993-1002, 2004.

T. W. Kurtz, Treating the metabolic syndrome: telmisartan as a peroxisome proliferator-activated receptor-gamma activator, Acta Diabetol, vol.42, pp.9-16, 2005.

Y. Amano, T. Yamaguchi, K. Ohno, T. Niimi, M. Orita et al., Structural basis for telmisartan-mediated partial activation of PPAR gamma, Hypertens. Res, vol.35, pp.715-719, 2012.

Y. Wang, S. Qiao, D. Han, X. Rong, Y. Wang et al., Telmisartan improves insulin resistance: a meta-analysis, Am. J. Therapeut, 2018.
DOI : 10.1097/mjt.0000000000000733

C. S. Mizuno, A. G. Chittiboyina, F. H. Shah, A. Patny, T. W. Kurtz et al., Design, synthesis, and docking studies of novel benzimidazoles for the treatment of metabolic syndrome, J. Med. Chem, vol.53, pp.1076-1085, 2010.

A. Casimiro-garcia, G. F. Filzen, D. Flynn, C. F. Bigge, J. Chen et al., Discovery of a series of imidazo[4,5-b]pyridines with dual activity at angiotensin II type 1 receptor and peroxisome proliferator-activated receptor-?, J. Med. Chem, vol.54, pp.4219-4233, 2011.

A. Casimiro-garcia, R. J. Heemstra, C. F. Bigge, J. Chen, F. A. Ciske et al., Design, synthesis, and evaluation of imidazo[4,5-c]pyridin-4-one derivatives with dual activity at angiotensin II type 1 receptor and peroxisome proliferator-activated receptor-?, Bioorg. Med. Chem. Lett, vol.23, pp.767-772, 2013.

Y. Lamotte, N. Faucher, J. Sançon, O. Pineau, S. Sautet et al., Discovery of novel indazole derivatives as dual angiotensin II antagonists and partial PPAR? agonists, Bioorg. Med. Chem. Lett, vol.24, pp.1098-1103, 2014.

A. G. Chittiboyina, C. S. Mizuno, P. V. Desai, A. Patny, T. W. Kurtz et al., Design, synthesis, and docking studies of novel telmisartan-glitazone hybrid analogs for the treatment of metabolic syndrome, Med. Chem. Res, vol.18, pp.589-610, 2009.

G. García, M. Rodríguez-puyol, R. Alajarín, I. Serrano, P. Sánchez-alonso et al.,

. Díez-marqués, Losartan-antioxidant hybrids: novel molecules for the prevention of hypertension-induced cardiovascular damage, J. Med. Chem, vol.52, pp.7220-7227, 2009.

G. García, I. Serrano, P. Sánchez-alonso, M. Rodríguez-puyol, R. Alajarín et al., New losartan-hydrocaffeic acid hybrids as antihypertensive-antioxidant dual drugs: ester, amide and amine linkers, Eur. J. Med. Chem, vol.50, pp.90-101, 2012.

M. C. Breschi, V. Calderone, M. Digiacomo, M. Macchia, A. Martelli et al., New no-releasing pharmacodynamic hybrids of losartan and its active metabolite: design, synthesis, and biopharmacological properties, J. Med. Chem, vol.49, pp.2628-2639, 2006.

C. R. Ganellin, A. Fkyerat, B. Bang-andersen, S. Athmani, W. Tertiuk et al., A novel series of (Phenoxyalkyl)imidazoles as potent H3-Receptor histamine antagonists, J. Med. Chem, vol.39, pp.3806-3813, 1996.

J. Huang, Peroxisome proliferator-activated receptor-independent ablation of cyclin D1 by thiazolidinediones and their derivatives in breast cancer cells, Mol. Pharmacol, vol.67, pp.1342-1348, 2005.

V. Santagada, F. Fiorino, E. Perissutti, B. Severino, S. Terracciano et al., A convenient synthesis by microwave irradiation of an active metabolite (EXP-3174) of losartan, Tetrahedron Lett, vol.44, pp.2835-2841, 2003.

K. Rikimaru, T. Wakabayashi, H. Abe, H. Imoto, T. Maekawa et al.,

J. Kawakami, M. Sakamoto, C. D. Funami, G. P. Mol, K. A. Snell et al.,

D. R. Sang, T. Dougan, N. Tanaka, Y. Katayama, Y. Horiguchi et al., A new class of non-thiazolidinedione, non-carboxylic-acid-based highly selective peroxisome proliferator-activated receptor (PPAR) ? agonists: design and synthesis of benzylpyrazole acylsulfonamides, Bioorg. Med. Chem, vol.20, pp.714-733, 2012.

R. Jeon and S. Park, Synthesis and biological activity of Benzoxazole containing thiazolidinedione derivatives, Arch Pharm. Res. (Seoul), pp.1099-1105, 2004.

J. E. Cobb, S. G. Blanchard, E. G. Boswell, K. K. Brown, P. S. Charifson et al.,

W. Lenhard, J. Oliver, M. Oplinger, D. J. Pentti, K. D. Parks et al.,

N. Tong, Benzoylphenyl)-l-tyrosine PPAR? agonists. 3. Structure?Activity relationship and optimization of the N-Aryl substituent, J. Med. Chem, vol.41, issue.2, pp.5055-5069, 1998.

C. Fruit and P. Mueller, Intramolecular asymmetric amidations of sulfonamides and sulfamates catalyzed by chiral dirhodium (II) complexes, Helv. Chim. Acta, vol.87, pp.1607-1615, 2004.
DOI : 10.1002/hlca.200490148

M. Schupp, L. D. Lee, N. Frost, S. Umbreen, B. Schmidt et al., Regulation of peroxisome proliferator-activated receptor activity by losartan metabolites, Hypertension, vol.47, pp.586-589, 2006.

M. Paramanik, R. Singh, S. Mukhopadhyay, and S. K. Ghosh, Catalytic nucleophilic fluorination by an imidazolium ionic liquid possessing trialkylphosphine oxide functionality, J. Fluorine Chem, vol.178, pp.47-55, 2015.
DOI : 10.1016/j.jfluchem.2015.06.022

M. Meyer, S. Kuntz, I. Grillier-vuissoz, H. Martin, L. Richert et al., Synthesis and anti-proliferative activity of new biphenyle-benzylidenethiazolidine-2,4-dione bis-adducts containing various heterocyclic cores, Lett. Drug Des. Discov, vol.11, pp.256-264, 2014.
DOI : 10.2174/15701808113106660080

URL : https://hal.archives-ouvertes.fr/hal-01094215

M. Journet, D. Cai, L. M. Dimichele, and R. D. Larsen, Highly efficient synthesis of ?,?-acetylenic aldehydes from terminal alkynes using DMF as the formylating reagent, Tetrahedron Lett, vol.39, issue.98, pp.1352-1357, 1998.

M. Journet, D. Cai, J. J. Kowal, and R. D. Larsen, Highly efficient and mild synthesis of variously 5-substituted-4-carbaldehyde-1,2,3-triazole derivatives, Tetrahedron Lett, vol.42, pp.1923-1925, 2001.

E. Balducci, L. Bellucci, E. Petricci, M. Taddei, and A. Tafi, Microwave-assisted intramolecular huisgen cycloaddition of azido alkynes derived from ?-amino acids, J. Org. Chem, vol.74, pp.1314-1321, 2009.

B. R. Henke, S. G. Blanchard, M. F. Brackeen, K. K. Brown, J. E. Cobb et al., Benzoylphenyl)-l-tyrosine PPAR? agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents, J. Med. Chem, vol.41, issue.2, pp.5020-5036, 1998.

D. J. Carini, J. V. Duncia, P. E. Aldrich, A. T. Chiu, A. L. Johnson et al., Nonpeptide angiotensin II receptor antagonists: the discovery of a series of N-(biphenylylmethyl)imidazoles as potent, orally active antihypertensives, J. Med. Chem, vol.34, pp.2525-2547, 1991.

V. Zoete, A. Grosdidier, and O. Michielin, Peroxisome proliferator-activated receptor structures: ligand specificity, molecular switch and interactions with regulators, Biochim. Biophys. Acta BBA-Mol. Cell Biol. Lipids, vol.1771, pp.915-925, 2007.

R. A. Laskowski and M. B. Swindells, LigPlot+: multiple ligand-protein interaction diagrams for drug discovery, J. Chem. Inf. Model, vol.51, pp.2778-2786, 2011.

D. J. Parks, N. C. Tomkinson, M. S. Villeneuve, S. G. Blanchard, and T. M. Willson, Differential activity of rosiglitazone enantiomers at PPAR?, Bioorg. Med. Chem. Lett, vol.8, pp.664-671, 1998.

I. N. Colmers, S. L. Bowker, and J. A. Johnson, Thiazolidinedione use and cancer incidence in type 2 diabetes: a systematic review and meta-analysis, Diabetes Metab, vol.38, pp.475-484, 2012.

K. A. Szychowski, M. L. Leja, D. V. Kaminskyy, U. E. Binduga, O. R. Pinyazhko et al., Study of novel anticancer 4-thiazolidinone derivatives, Chem. Biol. Interact, vol.262, pp.46-56, 2017.

K. A. Szychowski, M. L. Leja, D. V. Kaminskyy, A. P. Kryshchyshyn, U. E. Binduga et al., Anticancer properties of 4-thiazolidinone derivatives depend on peroxisome proliferator-activated receptor gamma (PPAR?), Eur. J. Med. Chem, vol.141, pp.162-168, 2017.

S. Prost, F. Relouzat, M. Spentchian, Y. Ouzegdouh, J. Saliba et al., Erosion of the chronic myeloid leukaemia stem cell pool by PPAR? agonists, Nature, vol.525, pp.380-383, 2015.

S. Mazerbourg, S. Kuntz, I. Grillier-vuissoz, A. Berthe, M. Geoffroy et al., Reprofiling of troglitazone towards more active and less toxic derivatives: a new hope for cancer treatment?, Curr. Top. Med. Chem, vol.16, pp.2115-2124, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01281602

S. Salamone, C. Colin, I. Grillier-vuissoz, S. Kuntz, S. Mazerbourg et al., Synthesis of new troglitazone derivatives: anti-proliferative activity in breast cancer cell lines and preliminary toxicological study, Eur. J. Med. Chem, vol.51, pp.206-215, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00746870

M. Meyer, S. Foulquier, G. Monard, F. Dupuis, I. Grillier-vuissoz et al., New losartan derivatives with potential dual activity as angiotensin II receptor blocker and peroxisome proliferator activated receptor gamma activator, Ann. Cardiol. Angeiol, vol.61, pp.11-12, 2012.

H. E. Gottlieb, V. Kotlyar, and A. Nudelman, NMR chemical shifts of common laboratory solvents as trace impurities, J. Org. Chem, vol.62, pp.7512-7515, 1997.

G. M. Morris, R. Huey, W. Lindstrom, M. F. Sanner, R. K. Belew et al., AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility, J. Comput. Chem, vol.30, pp.2785-2791, 2009.

M. F. Sanner, A. J. Olson, and J. Spehner, Reduced surface: an efficient way to compute molecular surfaces, Biopolymers, vol.38, pp.1097-0282, 1996.

, The PyMOL Molecular Graphics System, 2015.